Definitive Contract HHSN266200400068C
Award Date 9/30/04
Potential Completion Date 7/31/10
Potential Value $13M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Not listed
Number Of Offers Received
13
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the Department of Health and Human Services (HHS), to the University of Alabama at Birmingham (UAB). The award is a delivery order under the NIAID Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery Contract, with a ceiling value of $847,402.67. The contract is for biomedical research and development, with no set-aside designation. UAB, a non-profit educational...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Alabama at Birmingham (UAB). The $2,171,785.57 delivery order supports NIAID protocol #07-0012, a study to enroll male participants and evaluate a treatment for an unspecified infectious disease. The contract does not have a set-aside designation. The contract has two subcontractors: the University of Southern...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Alabama at Birmingham (UAB) to provide a "SUPPLEMENT TO COMPREHENSIVE PANEL FOR VIRUSES". The $26,500.00 Firm Fixed Price contract was awarded on March 24, 2015 as a Delivery Order under the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC). The contract has no set-aside designation. As a leading...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $978,590.76 Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB) on August 15, 2014 for a "Comprehensive Panel for Viruses" requirement. This Delivery Order was placed under NIAID's In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery, Indefinite Quantity (IDIQ) contract and had a completion date of September 29, 2015. UAB, a public research university and academic...
- This federal contract award is an administrative change and deobligation of funding for Contract ID 00266200105D266015439, originally awarded on May 15, 2001 to the University of Alabama at Birmingham (UAB), a public research university. The contract had a ceiling value of $5,990,395.16 and was a Definitive Contract with a Cost No Fee pricing type. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB). The $9,327,649.94 contract is for "Targeted Clinical Research to Address Select Viral Infections" and does not have a set-aside designation. The contract includes clinical research at multiple sites, including UAB and its subcontractors, to address viral infections. Subcontractors...
- This is a definitive cost-no-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to the University of Alabama at Birmingham (UAB) for research and development facilities. The contract has a ceiling value of $51,806,163.19 and a completion date of December 31, 2008. UAB, a public research university and academic medical center, has extensive experience in federal contracting and grants, particularly in areas such as cancer...
- This federal contract award, with an ID of HHSN272201100016I|HHSN27200013, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract is for "IN VITRO ASSESSMENT FOR ANTIMICROBIAL ACTIVITY" and was awarded to the University of Alabama at Birmingham (UAB), a public research university, on September 13, 2016. The contract has a ceiling value of $1,066,560.00 and runs through September 15, 2017. It is a...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB), doing business as U A B, for a "COMPREHENSIVE PANEL FOR VIRUSES" contract with a ceiling value of $1,053,577.42. The contract is under the broader In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery Contract (IDC) and has a completion date of September 29, 2016. UAB is a non-profit, public research university...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) on August 22, 2017. The contract has a potential value of $845,508.52 and a completion date of September 15, 2018. The contract is for in vitro assessment for antimicrobial activity and a comprehensive viral screening panel. This delivery order is...